FDA Approves Tzield, First Drug That Delays Type 1 Diabetes Progression The US FDA approves the drug Tzield, or Teplizumab, which reportedly delays the onset of Type-1 Diabetes. by Andi C.
Chatbots Could Be Suffering from Confirmation Bias When Tackling Controversial Issues: John Hopkins Study